The first pill to treat postpartum depression has been approved by U.S. health officials

  • 📰 L.A. Times Health
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 59%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

U.S. health officials approved Zurzuvae, the first pill specifically intended to treat severe depression after childbirth. The condition affects thousands of new mothers in the U.S. each year.

, in 2019, though it isn’t widely used because of its $34,000 price tag and the logistics of administering it.

Sahar McMahon, 39, had never experienced depression until after the birth of her second daughter in late 2021. She agreed to enroll in a study of the drug, known chemically as zuranolone, after realizing she no longer wanted to spend time with her children.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 364. in HEALTH

Health Health Latest News, Health Health Headlines